Study Notes from the Adhyan 2.0 International Speaker Program

Transcript Study Notes

Introduction to the Webinar

  • Host Introduction: Dr. Shweta from Globe Pharma Publications.

  • Purpose: Sponsored speaker program by Olympic Pharmaceuticals Limited for advancing gynecologic care.

  • Main Focus: The program, titled "Adhyan 2.0," aims to bring together experts to discuss evidence-based approaches in women’s health, specifically on:

    • Endometriosis

    • Heavy menstrual bleeding

    • Infertility

Opening Remarks by Shikhar Gulati

  • Welcome Address: General Manager, Sales and Marketing, Olympic Pharmaceuticals, welcomes doctors and attendees to the program.

  • Importance of the Session: Aim to share insights from experts focusing on practical guideline-driven learnings for clinicians.

Introduction of Expert Speakers

  • Dr. Herb Taylor (Yale School of Medicine): Focus on endometriosis challenges and treatment.

  • Dr. Krishna Kumari: Senior consultant discussing management of heavy menstrual bleeding.

  • Dr. Ritu Khanna: Senior consultant on infertility and reproductive medicine, discussing CoQ10 and combinations in infertility.

  • Dr. Komal Chauhan: Moderator with over 25 years of clinical experience, Vice President of FOXI.

Session on Endometriosis by Dr. Herb Taylor

Overview of Endometriosis

  • Prevalence: Affects approximately 10% of reproductive-age women.

  • Common Misdiagnosis: Often underdiagnosed or misdiagnosed, especially in women presenting with infertility.

  • Symptoms: Often includes pelvic pain and infertility, which complicates management strategies.

Diagnostic Challenges

  • Time to Diagnosis: Takes an average of 6-12 years from symptom onset.

  • Normalization of Pain: Menstrual pain is often dismissed, leading to delayed diagnosis.

  • Symptoms Confusion: Many symptoms overlap with other disorders (e.g., irritable bowel syndrome, interstitial cystitis).

Treatment Considerations

  • Progressive Nature: Early diagnosis can prevent pain progress and complications.

  • Laparoscopy: Initially considered a gold standard, but may not be effective for minor or early endometriosis.

  • Medical Therapy: Focus on hormonal treatments as first-line therapy.

Systemic Impacts of Endometriosis

  • Systemic Effects: Involves inflammation and psychological effects (depression, anxiety).

  • Long-term Outcomes: Women may experience reduced life quality due to recurrent pain and other symptoms.

Recommendations for Clinicians

  • Clinical Diagnosis: Consider signs and symptoms to diagnose rather than relying solely on imaging or surgical findings.

  • Early Intervention: Start treatment immediately, particularly with non-steroidal anti-inflammatory drugs (NSAIDs) and contraceptives.

  • Lifestyle Impacts: Aim to improve quality of life through early recognition of symptoms and prompt care.

Presentation on Heavy Menstrual Bleeding (HMB) by Dr. Krishna Kumari

Definition and Epidemiology

  • Definition of HMB: Excessive menstrual blood loss affecting quality of life, exceeding 80 mL.

  • Prevalence: Affects up to 30% of reproductive-age women.

Diagnosis

  • Assessing History: Importance of detailed menstrual history, duration, and volume of bleeding.

  • Specific Symptoms: Notable symptoms include changing pads every 2 hours, night-time changing, and passing large clots.

  • Laboratory Workup: Complete blood count (CBC), pregnancy test, thyroid function test (TFT), and other relevant lab tests.

  • Imaging: Transvaginal ultrasound for assessing any structural causes like polyps or fibroids.

Management Strategies

  • Initial Management: Depends on severity (mild, moderate, severe) and age of the patient.

  • First-Line Therapy: Options include NSAIDs, hormonal contraceptives, and tranexamic acid.

  • Surgical Interventions: Reserved for patients who do not respond to medical management or have severe cases.

Hormonal Treatment Options

  • Combined Oral Contraceptives (COCs): Effective in reducing menstrual flow.

  • Progestin Therapy: Especially useful for patients with hyperandrogenic symptoms.

  • LNG IUS (Levonorgestrel Intrauterine System): Effective in managing HMB but may not be acceptable for all patients.

Presentation on Fertility and Nutrition by Dr. Ritu Khanna

Fertility Overview

  • Prevalence of Infertility: 10-15% of married couples experience infertility, with rising numbers.

  • Common Causes: Lifestyle factors, stress, obesity, and aging significantly impact fertility.

Role of Oxidative Stress

  • Reactive Oxygen Species: Moderate levels are essential; excess leads to cellular damage and affects oocyte and embryo quality.

  • Antioxidants: Necessary to counteract the effects of oxidative stress.

Targeted Nutritional Supplements

  • CoQ10: Maintains mitochondrial function and protects cells from oxidative stress.

  • Selenium and Lycopene: Support antioxidant functions and maintain oocyte quality.

  • N-Acetylcysteine (NAC): Reduces inflammation and improves ovulation in patients with PCOS.

Recommendations for Supplementation

  • Combining Antioxidants: Using CoQ10 with selenium and lycopene can have synergistic effects on fertility.

  • Lifestyle Modification: Encourage overall improvements like diet and reduced stress to enhance fertility outcomes.

Conclusion

  • Comprehensive Approach: Acknowledge the need for combined therapies to support female fertility through lifestyle changes, nutritional interventions, and appropriate medical treatments.

  • Importance of Education: Continuous education for healthcare providers to stay updated with management practices for conditions like endometriosis, HMB, and infertility.

Conclusion of the Webinar

  • Closing Remarks: Dr. Komal Chauhan wraps up the session, thanking speakers and participants, emphasizing the importance of collaboration in enhancing clinical practices through learned insights from the discussions.